Assessing exposure levels of acrylamide

Acrylamide and Other Hazardous Compounds in Heat-Treated Foods

Volumn , Issue , 2006, Pages 214-230

  Konnings, Erik J M ^a   Hogervorst, Janneke G F ^b   Schouten, Leo J ^b   van den Brandt, Piet A ^b  

^a Voedsel en Waren Autoriteit Netherlands   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903656047     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-84569-011-3.50010-0     Document Type: Chapter

References (76)

1. Acrylamide, Workshop Proceedings: Update-Scientific Issues Uncertainties, and Research Strategies 2004, April 13-15, 2004, Illinois, Chicago.
2. Bag, Switzerland Assessment of acrylamide intake by Duplicate Diet Study 2002, Swiss Federal Office of Public Health. http://www.bag.admin.ch/verbrau/aktuell/d/DDS%20acrylamide%20preliminary%20communication.pdf.
3. Barber D.S., Hunt J.R., et al. Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing. Neurotox 2001, 22:341-353.
4. Barber D.S., Hunt J., et al. Determination of acrylamide and glycidamide in rat plasma by reversed-phase high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001, 758(2):289-293.
5. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem Res Toxicol 1997, 10(1):78-84.
6. Bergmark E., Calleman C.J., et al. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol Appl Pharmacol 1991, 111(2):352-363.
7. Bergmark E., Calleman C.J., et al. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol Appl Pharmacol 1993, 120(1):45-54.
8. Besarati Nia A., Pfeifer G.P. Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst 2003, 95(12):889-896.
9. Besarati Nia A., Pfeifer G.P. Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst 2004, 96(13):1023-1029.
10. Besarati Nia A., Pfeifer G.P. DNA adduction and mutagenic properties of acrylamide. Mutat Res 2005, 580(1-2):31-40.
11. Boettcher M.I., Angerer J. Determination of the major mercapturic acids of acrylamide and glycidamide in human urine by LC-ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 824(1-2):283-294.
12. Boettcher M.I., Bolt H.M., et al. Excretion of mercapturic acids of acrylamide and glycidamide in human urine after single oral administration of deuterium-labelled acrylamide. Arch Toxicol 2005, 1-7.
13. Boettcher M.I., Schettgen T., et al. Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. Mutat Res 2005, 580(1-2):167-176.
14. Bull P.J., Brooke R.K., et al. An occupational hygiene investigation of exposure to acrylamide and the role for urinary S-carboxyethyl-cysteine (CEC) as a biological marker. Ann Occup Hyg 2005, 49(8):683-690.
15. Burek J., Albee R., et al. Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery. J Environ Path Tox 1980, 4:157-182.
16. Calleman C.J., Bergmark E., et al. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem Res Toxicol 1990, 3(5):406-412.
17. Calleman C.J., Wu Y., et al. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol 1994, 126(2):361-371.
18. CIAA, Confederation of the food and drink industries of the EU. Acrylamide status report December 2004. A summary of the efforts and progress achieved to date by the European Food and Drink Industry (CIAA) in lowering levels of acrylamide in food.
19. Costa L.G., Deng H., et al. Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral, neurochemical and morphological studies. Toxicology 1995, 98(1-3):151-161.
20. Croft M., Tong P., et al. Australian survey of acrylamide in carbohydrate-based foods. Food Add Cont 2004, 21(8):721-736.
21. Dixit R., Seth P.K., et al. Metabolism of acrylamide into urinary mercapturic acid and cysteine conjugates in rats. Drug Metab Dispos 1982, 10(2):196-197.
22. Doerge D.R., Young J.F., et al. Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice. Toxicol Appl Pharmacol 2005, 202(3):258-267.
23. Doerge D.R., Young J.F., et al. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Toxicol Appl Pharmacol 2005, 208(3):199-209.
24. Dybing E., Farmer P.B., et al. Human exposure and internal dose assessments of acrylamide in food. Food and Chem Tox 2005, 43:365-410.
25. EC Risk assessment of acrylamide 2002, (CAS No. 79-06-1, EINECS No. 201-173-7) Summary Risk Assessment Report, European Commission, Joint Research Center, European Chemicals, Bureau Ispra, Italy, Available:. http://ecb.jrc.it/existing-chemicals/.
26. FAO/WHO Health implications of acrylamide in food. Report of a joint FAO/WHO Consultation 2002, World Health Organization, Geneva, 25-27 June 2002. Available. http://www.who.int/fsf/acrylamide/SummaryReportFinal.pdf.
27. Farmer P.B., Brown K., et al. DNA adducts: Mass spectrometry methods and future prospects. Toxicol Appl Pharmacol 2005, 207(2 Suppl):293-301.
28. Fennell T.R., Sumner S.C., et al. Metabolism and Hemoglobin Adduct Formation of Acrylamide in Humans. Toxicol Sci 2005, 85(1):447-459.
29. Gamboa Da Costa G., Churchwell M.I., et al. DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem Res Toxicol 2003, 16(10):1328-1337.
30. Ghanayem B.I., McDaniel L.P., et al. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol Sci 2005, 88(2):311-318.
31. Ghanayem B.I., Witt K.L., et al. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect. Biol Reprod 2005, 72(1):157-163.
32. Ghanayem B.I., Witt K.L., et al. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: Evidence consistent with a glycidamide-mediated effect. Mutat Res 2005, 578(1-2):284-297.
33. Grob K. Reduction of exposure to acrylamide: achievements, potential of optimization, and problems encountered from the perspectives of a Swiss enforcement laboratory. J. AOAC Int 2005, 88(1):253-261.
34. Hagmar L., Tornqvist M., et al. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 2001, 27(4):219-226.
35. Hagmar L., Wirfalt E., et al. Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat Res 2005, 580(1-2):157-165.
36. Hertz-Picciotto I. Epidemiology and quantitative risk assessment: a bridge from science to policy. Am J Public Health 1995, 85:484-491.
37. Hilbig A., Freidrank N., et al. Estimation of the dietary intake of acrylamide by German infants, children and adolescents as calculated from dietary records and available data on acrylamide levels in food groups. Int J Hyg Environ Health 2004, 207(5):463-471.
38. Hoenicke K., Gatermann R. Studies on the stability of acrylamide in food during storage. J AOAC Int 2005, 88(1):268-273.
39. IARC Acrylamide. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 1994, 60. International Agency for Research on Cancer, Lyon.
40. Jifsan Acrylamide in food workshop: Scientific issues 2002, Uncertainties, and Research strategies, Rosemont (IL, USA), 28-30 October 2002. Available. http://www.jifsan.umd.edu/acrylamide/acrylamide_workshop.html.
41. Johnson K., Gorzinski S., et al. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Tox Appl Pharm 1986, 85:154-168.
42. Jones K., Garfitt S., et al. Correlation of haemoglobin-acrylamide adducts with airborne exposure: An occupational survey. Toxicol Lett 2005, Epub.
43. Klaffka H., Fauhl C., et al. Results from two interlaboratory comparison tests organized in Germany at the EU level for analysis of acrylamide in food. J AOAC Int 2005, 88(1):292-298.
44. Konings E.J.M., Baars A.J., et al. Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Tox 2003, 41:1569-1779.
45. Kutting B., Schettgen T., et al. Influence of Diet on Exposure to Acrylamide - Reflections on the Validity of a Questionnaire. Ann Nutr Metab 2005, 49(3):173-177.
46. Lineback D., Wenzl T., et al. Overview of acrylamide monitoring databases. J AOAC Int 2005, 88(1):246-252.
47. Maniere I., Godard T., et al. DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide. Mutat Res 2005, 580(1-2):119-129.
48. Manjanatha M.G., Aidoo A., et al. Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ Mol Mutagen 2005, Epub.
49. Miller M.J., Carter D.E., et al. Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicol Appl Pharmacol 1982, 63(1):36-44.
50. Owen L.M., Castle L., et al. Acrylamide analysis: assessment of results from six rounds of Food Analysis Performance Assessment Scheme (FAPAS) Proficiency Testing. J AOAC Int 2005, 88(1):285-291.
51. Perez H.L., Cheong H.K., et al. Simultaneous analysis of hemoglobin adducts of acrylamide and glycidamide by gas chromatography-mass spectrometry. Anal Biochem 1999, 274(1):59-68.
52. Roach J.A.G., Andrzejewski D., et al. Rugged LC-MS/MS survey analysis for acrylamide in foods. J Agricultural Food Chem 2003, 51:7547-7554.
53. Samet J.M., Schnatter R., Gibb H. Epidemiology and risk assessment. Am J Epidemiol 1998, 148:929-936.
54. SCF European Commission Scientific Committee on Food. Opinion on new Findings Regarding the Presence of Acrylamide in Food 2002, 3 July 2002. Available. http://europa.eu.int/comm/food/fs/sc/scf/out131_en.pdf.
55. Schabacker J., Schwend T., et al. Reduction of acrylamide uptake by dietary proteins in a caco-2 gut model. J Agric Food Chem 2004, 52(12):4021-4025.
56. Schettgen T., Broding H.C., et al. Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol Lett 2002, 134(1-3):65-70.
57. Schettgen T., Weiss T., et al. A first approach to estimate the internal exposure to acrylamide in smoking and non-smoking adults from Germany. Int J Hyg Environ Health 2003, 206(1):9-14.
58. Schettgen T., Kutting B., et al. Trans-placental exposure of neonates to acrylamide - a pilot study. Int Arch Occup Environ Health 2004, 77(3):213-216.
59. Schettgen T., Rossbach B., et al. Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 2004, 207(6):531-539.
60. Segerback D., Calleman C.J., et al. Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 1995, 16(5):1161-1165.
61. Shore R.E., Iyer V., et al. Use of human data in quantitative risk assessment of carcinogens: impact on epidemiologic practice and the regulatory process. Regul Toxicol Pharmacol 1992, 15:180-221.
62. SNFA Acrylamide is formed during the preparation of food and occurs in many foodstuffs 2002, Press release from Livsmedelsverket, Swedish National Food Administration, Uppsala, April 24, 2002. Internet. http://www.slv.se.
63. SNFA Analytical Methodology and Survey Result for Acrylamide in Foods 2002, Swedish National Food Administration, Uppsala, April 26, 2002. Available. http://www.slv.se.
64. SNFA Acrylamide in foodstuffs, Consumption and intake 2002, National Food Administration, Uppsala, April 26, 2002. Available. http://www.slv.se.
65. Solomon J.J., Fedyk J., et al. Direct alkylation of 2-deoxynucleosides and DNA following in vitro reaction with acrylamide'. Cancer Res 1985, 45(8):3465-3470.
66. Sörgel F.R., Weissenbacher R., et al. Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans. Chemotherapy 2002, 48(6):267-274.
67. Sumner S.C., MacNeela J.P., et al. Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem Res Toxicol 1992, 5(1):81-89.
68. Sumner S.C., Selvaraj L., et al. Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem Res Toxicol 1997, 10(10):1152-1160.
69. Sumner S.C., Fennell T.R., et al. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999, 12(11):1110-1116.
70. Tareke E., Ryberg P., et al. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002, 50:4998-5006.
71. Twaddle N.C., McDaniel L.P., et al. Determination of acrylamide and glycidamide serum toxicokinetics in B6C3F1 mice using LC-ES/MS/MS. Cancer Lett 2004, 207(1):9-17.
72. Van Den Brandt P.A., Voorrips L., et al. The contribution of Epidemiology. Food Chem Tox 2002, 40:387-424.
73. Vesper H.W., Licea-Perez H., et al. Chemistry and Safety of Acrylamide in Food. Pilot study on the impact of potato chips consumption on biomarkers of acrylamide exposure. 2005, 561:89-96. Springer Science + Business Media, Inc., New York. M. Friedman, D.S. Mottram (Eds.).
74. Wenzl T., Anklam E. Evaluation of results of an interlaboratory comparison test on determination of acrylamide in crispbread samples. J AOAC Int 2005, 88(5):1413-1418.
75. WHO Acrylamide. Guidelines for drinking-water quality 1996, 2. Health critria and other supporting information, International Programme on Chemical Safety, World Health Organization, Geneva. 2nd edn.
76. WHO Joint FAO/WHO expert committee on food additives 2005, Rome 8-17 February.